Related references
Note: Only part of the references are listed.Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation ARIC Study
Joseph J. Decker et al.
STROKE (2019)
Platelet activity and hypercoagulation in type 2 diabetes
Lesha Pretorius et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2
Menno V. Huisman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score
Gregory Y. H. Lip et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
Tze-Fan Chao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2015)
Additive effect of the metabolic syndrome score to the conventional CHADS2 score for the thromboembolic risk stratification of patients with atrial fibrillation
Chia-Ti Tsai et al.
HEART RHYTHM (2014)
Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
Tomas Karpati et al.
POPULATION HEALTH METRICS (2014)
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts
Jonathan P. Piccini et al.
CIRCULATION (2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2013)
Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations) A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2012)
Effect of pre-diabetes on future risk of stroke: meta-analysis
Meng Lee et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts
R. Santos-Oliveira et al.
DIABETOLOGIA (2011)
Stroke Risk Stratification in a Real-World Elderly Anticoagulated Atrial Fibrillation Population
Daniela Poli et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2011)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Jonas Bjerring Olesen et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range
Feng Ning et al.
DIABETES CARE (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.
Elizabeth Selvin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the US Preventive Services Task Force
Mark Helfand et al.
ANNALS OF INTERNAL MEDICINE (2009)
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
Margaret C. Fang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke
Sarah E. Vermeer et al.
STROKE (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Association of hemoglobin A1c with cardiovascular disease and mortality in adults:: The European prospective investigation into cancer in Norfolk
KT Khaw et al.
ANNALS OF INTERNAL MEDICINE (2004)
Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks - A prospective cohort study
D Tanne et al.
STROKE (2004)
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community - The Framingham Heart Study
TJ Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
